Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

The management of post-transplantation recurrence of hepatocellular carcinoma

Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin

Clin Mol Hepatol. 2022;28(1):1-16. Published online October 5, 2021

DOI: https://doi.org/10.3350/cmh.2021.0217

View: 7750 Download: 326 Web of Science: 24 Crossref: 27

Original Article

Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma

Incheon Kang, Jae Geun Lee, Sung Hoon Choi, Hyun Jeong Kim, Dai Hoon Han, Gi Hong Choi, Myoung Soo Kim, Jin Sub Choi, Soon Il Kim, Dong Jin Joo

Clin Mol Hepatol. 2021;27(4):589-602. Published online July 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0038

View: 5697 Download: 242 Web of Science: 18 Crossref: 19

Editorial

Can hepatocellular carcinoma recurrence be prevented after liver transplantation?

Jong Man Kim

Clin Mol Hepatol. 2021;27(4):562-563. Published online September 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0276

View: 3649 Download: 126 Web of Science: 2 Crossref: 2

Review

Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation

Jongwook Oh, Jong Man Kim

Clin Mol Hepatol. 2020;26(1):1-6. Published online March 26, 2019

DOI: https://doi.org/10.3350/cmh.2019.0023

View: 15506 Download: 607 Web of Science: 22 Crossref: 23

The use of immunosuppression in autoimmune hepatitis: A current literature review

Angela Cropley, Martin Weltman

Clin Mol Hepatol. 2017;23(1):22-26. Published online March 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0089

View: 28994 Download: 418 Web of Science: 15 Crossref: 18

Original Article

Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection

Jong Man Kim, Kwang-Woong Lee, Gi-Won Song, Bo-Hyun Jung, Hae Won Lee, Nam-Joon Yi, ChoonHyuck David Kwon, Shin Hwang, Kyung-Suk Suh, Jae-Won Joh, Suk-Koo Lee, Sung-Gyu Lee

Clin Mol Hepatol. 2016;22(3):366-371. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0022

View: 9115 Download: 142 Crossref: 1

Review

Prevention of Hepatitis B reactivation in the setting of immunosuppression

Venessa Pattullo

Clin Mol Hepatol. 2016;22(2):219-237. Published online June 13, 2016

DOI: https://doi.org/10.3350/cmh.2016.0024

View: 16677 Download: 651 Web of Science: 81 Crossref: 83

Original Article

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation

Ju-Yeun Lee, Yul Hee Kim, Nam-Joon Yi, Hyang Sook Kim, Hye Suk Lee, Byung Koo Lee, Hyeyoung Kim, Young Rok Choi, Geun Hong, Kwang-Woong Lee, Kyung-Suk Suh

Clin Mol Hepatol. 2014;20(2):192-203. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.192

View: 9549 Download: 95 Web of Science: 23 Crossref: 22

2

Treatment of Chronic Hepatitis B ; Antiviral Therapy in Hepatitis B Carriers Undergoing Immunosuppressive Treatment or Cytotoxic Chemotherapy

Jung Hwan Yoon

Clin Mol Hepatol. 2005;11(1):17-20. Published online January 1, 2000

View: 2280 Download: 12

3

Immune Response of Peripheral Blood Mononuclear cells to Core and NS3 Protein in Chronic Hepatitis C Virus (HCV) Infecton

Sook-Hyang Jeong, Min-Jin Yang*, Kee-Ho Lee*, Yeon-Sook Yun†, and Yo Han Choi‡

Clin Mol Hepatol. 2001;7(3):292-298. Published online January 1, 2000

View: 2176 Download: 13

1 |

Viewed By 5314	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5255	MAFLD: How is it different from NAFLD?
Viewed By 5156	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3871	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3808	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search